International Biotechnology Trust (LSE:IBT) LT-Debt-to-Total-Asset : 0.09 (As of Feb. 2024)

View and export this data going back to 1994. Start your Free Trial

What is International Biotechnology Trust LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. International Biotechnology Trust's long-term debt to total assests ratio for the quarter that ended in Feb. 2024 was 0.09.

International Biotechnology Trust's long-term debt to total assets ratio increased from Feb. 2023 (0.07) to Feb. 2024 (0.09). It may suggest that International Biotechnology Trust is progressively becoming more dependent on debt to grow their business.

International Biotechnology Trust LT-Debt-to-Total-Asset Historical Data

The historical data trend for International Biotechnology Trust's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

International Biotechnology Trust LT-Debt-to-Total-Asset Chart

International Biotechnology Trust Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.06

0.12

0.11

International Biotechnology Trust Semi-Annual Data
	Aug14	Feb15	Aug15	Feb16	Aug16	Feb17	Aug17	Feb18	Aug18	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.14	0.12	0.07	0.11	0.09

International Biotechnology Trust LT-Debt-to-Total-Asset Calculation

International Biotechnology Trust's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Aug. 2023 is calculated as

LT Debt to Total Assets (A: Aug. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Aug. 2023 )	/	Total Assets (A: Aug. 2023 )
	=	32.474	/	304.871
	=	0.11

International Biotechnology Trust's Long-Term Debt to Total Asset Ratio for the quarter that ended in Feb. 2024 is calculated as

LT Debt to Total Assets (Q: Feb. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Feb. 2024 )	/	Total Assets (Q: Feb. 2024 )
	=	27.669	/	320.769
	=	0.09

International Biotechnology Trust (LSE:IBT) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

International Biotechnology Trust LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of International Biotechnology Trust's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

International Biotechnology Trust (LSE:IBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » International Biotechnology Trust PLC (LSE:IBT) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

IBTl:UK

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.ibtplc.com

International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.

International Biotechnology Trust (LSE:IBT) Headlines

No Headlines